Literature DB >> 22223346

mRNA delivery through fibronectin associated liposome-apatite particles: a new approach for enhanced mRNA transfection to mammalian cell.

Fatema Tuj Zohra1, Yoshie Maitani, Toshihiro Akaike.   

Abstract

It was believed for a long time that mRNA is very unstable, and can not be used for therapeutic purposes. In the last decade, however, many research groups proved its transfection feasibility along with advantages and applications. Our investigation is aimed at establishing a potent and efficient mRNA delivery system. We previously reported that an inorganic-organic hybrid carrier by exploiting the advantages of inorganic nano apatite particles onto organic carrier DOTAP {N-[1-(2,3-dioleoloxy)propyl]-N,N,N-trimethyl ammonium chloride} and showed potential effect of carbonate apatite particles on each of the mRNA delivery steps in dividing and non-dividing cell. Here, we report on the development of a more efficient mRNA carrier by complexing ECM protein, fibronectin with the DOTAP-apatite carrier. The carrier showed enhanced uptake of luciferase mRNA both qualitatively and quantitatively. Accelerated cellular endocytosis rate was evaluated using labeled endosome. Finally expression of lucifearse mRNA was higher for fibronectin complexed carrier in compared to the uncoated one.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22223346     DOI: 10.1248/bpb.35.111

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

Review 1.  Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.

Authors:  S Guan; J Rosenecker
Journal:  Gene Ther       Date:  2017-01-17       Impact factor: 5.250

Review 2.  The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize.

Authors:  Miroslaw Janowski; Anna Andrzejewska
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-13       Impact factor: 10.183

3.  Biomaterials for mRNA delivery.

Authors:  Mohammad Ariful Islam; Emma K G Reesor; Yingjie Xu; Harshal R Zope; Bruce R Zetter; Jinjun Shi
Journal:  Biomater Sci       Date:  2015-08-17       Impact factor: 6.843

Review 4.  An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo.

Authors:  Md Motiar Rahman; Nan Zhou; Jiandong Huang
Journal:  Vaccines (Basel)       Date:  2021-03-11

5.  A Novel Graphene Quantum Dot-Based mRNA Delivery Platform.

Authors:  Ya Liu; Changhong Zhao; Alan Sabirsh; Lilei Ye; Xiaoqiu Wu; Hongbin Lu; Johan Liu
Journal:  ChemistryOpen       Date:  2021-04-07       Impact factor: 2.630

Review 6.  Lipid nanoparticles for mRNA delivery.

Authors:  Xucheng Hou; Tal Zaks; Robert Langer; Yizhou Dong
Journal:  Nat Rev Mater       Date:  2021-08-10       Impact factor: 66.308

Review 7.  Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.

Authors:  Lu Yang; Lin Tang; Ming Zhang; Chaoyong Liu
Journal:  Front Immunol       Date:  2022-07-15       Impact factor: 8.786

8.  Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer.

Authors:  Meike-Kristin Abraham; Karlheinz Peter; Tatjana Michel; Hans Peter Wendel; Stefanie Krajewski; Xiaowei Wang
Journal:  Nanotheranostics       Date:  2017-04-05

9.  Location of a single histidine within peptide carriers increases mRNA delivery.

Authors:  Jiaxi He; Songhui Xu; Qixin Leng; A James Mixson
Journal:  J Gene Med       Date:  2020-12-21       Impact factor: 4.565

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.